Michele Bellandi
Algemeen Directeur bij Vertex Pharmaceuticals (France) SAS
Profiel
Michele Bellandi is currently the Co-Chief Executive Officer at Vertex Pharmaceuticals (France) SAS since 2021 and Director at Vertex Pharmaceuticals (U.K.) Ltd.
since 2018.
He previously worked as the Chief Commercial Officer at Amryt Pharma Holdings Ltd.
Actieve functies van Michele Bellandi
Bedrijven | Functie | Begin |
---|---|---|
Vertex Pharmaceuticals (U.K.) Ltd.
Vertex Pharmaceuticals (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2011, Vertex Pharmaceuticals (U.K.) Ltd. is a subsidiary of Vertex Pharmaceuticals, Inc. that engages in research and experimental development on natural science. The company is based in London, UK. | Directeur/Bestuurslid | 15-10-2018 |
Vertex Pharmaceuticals (France) SAS
Vertex Pharmaceuticals (France) SAS Pharmaceuticals: MajorHealth Technology Part of Vertex Pharmaceuticals, Inc., Vertex Pharmaceuticals (France) SAS develops and manufactures pharmaceutical products. The company is based in Paris, France. The CEOs are Michele Bellandi, Jonathan Oppenheim. The French company was founded in 2011. | Algemeen Directeur | 11-06-2021 |
Eerdere bekende functies van Michele Bellandi
Bedrijven | Functie | Einde |
---|---|---|
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 31-03-2017 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Vertex Pharmaceuticals (U.K.) Ltd.
Vertex Pharmaceuticals (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2011, Vertex Pharmaceuticals (U.K.) Ltd. is a subsidiary of Vertex Pharmaceuticals, Inc. that engages in research and experimental development on natural science. The company is based in London, UK. | Commercial Services |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Vertex Pharmaceuticals (France) SAS
Vertex Pharmaceuticals (France) SAS Pharmaceuticals: MajorHealth Technology Part of Vertex Pharmaceuticals, Inc., Vertex Pharmaceuticals (France) SAS develops and manufactures pharmaceutical products. The company is based in Paris, France. The CEOs are Michele Bellandi, Jonathan Oppenheim. The French company was founded in 2011. | Health Technology |